You are here :
Home
Healthcare Market Research Reports
PRODUCT TITLE | PUBLISHED | |
---|---|---|
Asia-Pacific Microwave Ablation The Asia-Pacific Microwave Ablation Market was pegged at $15 million in 2013 and expected to be $31 million by 2018. Currently there are very few players in the Asia-Pacific Microwave Ablation market, major players being Synapse Medical, Microsilus Medical (U.K.) which recently entered into a strategic partnership with Angiodynamics (U.S). |
Upcoming | |
European Microwave Ablation The European Microwave Ablation Market was pegged at $27 million in 2013 and expected to be $45 million by 2018. Currently there are very few players in European Microwave Ablation market, major players being Synapse Medical, Microsilus Medical (U.K.) which recently entered into a strategic partnership with Angiodynamics (U.S). |
Upcoming | |
European Clinical Chemistry Although earlier, Europe showed a negative growth rate in the clinical chemistry market, in some countries revenues grew compared to 2011. Germany commanded the largest share (20%) at an estimated $652.8 million in 2013 and is expected to reach $853.3 million by 2018, at a CAGR of 5.8% from 2013 to 2018. The market can be segmented by geographies, end users, companies, and macro indicators. A deep-dive analysis of the top players of this market has been provided in this report. |
Upcoming | |
Asian Facial Interfaces The Asian Facial Interface market constitutes a growing market and a prime part of the Healthcare industry. Masks forms the major contributor in this market and is growing at a CAGR of 18.4% from 2013-2018. The market has been segmented on the basis of Products, Geographies, Endusers, Companies and Macroindicator. Deep dive analysis of the key players have been considered in this report. |
Upcoming | |
Americas Radiation Ablation The American Radiation Ablation Market, mainly driven by growing aging population, with increasing incidence, and prevalence of chronic diseases such as cancer and cardiovascular disorders, rapid acceptance of new medical technology, and well covered reimbursement system. The main companies operating in radiation ablation market and extensively covered in this report are Varian Medical Systems (U.S), and Elekta (Sweden). |
Upcoming | |
Asia-Pacific Radiation Ablation The Asia-Pacific Radiation Ablation Market was pegged at $559 million in 2013 and expected to be $899 million by 2018. It accounts for over 33% of the total ablation technologies market and expected to continue enjoying a major share in Radiation Ablation market. The main companies operating in Asia-Pacific radiation ablation market and extensively covered in this report are Varian Medical Systems (U.S), and Elekta (Sweden). |
Upcoming | |
European Radiation Ablation The European Radiation Ablation Market was pegged at $864 million in 2013 and expected to be $1223 million by 2018. The main companies operating in European radiation ablation devices market and extensively covered in this report are Varian Medical Systems (U.S), and Elekta (Sweden). |
Upcoming | |
Americas Radiofrequency Ablation The Global Radiofrequency Ablation Market, was pegged at $1160 million in 2013 and expected to be $2313 million by 2018. The key players in Radiofrequency Ablation sector are Covidien (Ireland), Boston Scientific (U.S.), Biosense Inc. (U.S.), St. Jude Medical (U.S.), AngioDynamics (U.S.) and Medtronic Inc. (U.S.). |
Upcoming | |
Asia-Pacific Radiofrequency Ablation The Asia-Pacific Radiofrequency Ablation Market was pegged at $303 million in 2013 and expected to be $650 million by 2018. The key players in Asia-Pacific Radiofrequency ablation sector are Covidien (Ireland), Boston Scientific (U.S.), Biosense Inc. (U.S.), St. Jude Medical (U.S.), AngioDynamics (U.S.) and Medtronic Inc. (U.S.). |
Upcoming | |
European Radiofrequency Ablation The European Radiofrequency Ablation Market was pegged at $1160 million in 2013 and expected to be $2313 million by 2018. The key players in European radiofrequency ablation therapy sector are Covidien (Ireland), Boston Scientific (U.S.), Biosense Inc. (U.S.), St. Jude Medical (U.S.), AngioDynamics (U.S.) and Medtronic Inc. (U.S.). |
Upcoming | |
Capnographs The “Global Capnographs Market”, mainly driven by increase chronically ill population, was pegged at $ 124 million in 2012 and expected to be $ 368 million by 2020, growing at a CAGR of 15.2%. The report analyzes the market of monitors by 2 segments such as Behind monitors and Handheld monitors. The main companies operating in Capnographs market and extensively covered in this report are Oridion (Covidien) (U.S.) is the global leader in the market, followed by Respironics (Philips) (Netherlands), Mindray (China), Welch Allyn (U.S.), and Smiths Medical (U.K.). |
Upcoming | |
Americas Ultrasound Ablation The American Ultrasound Ablation Market was pegged at $644 million in 2013 and expected to be $1155 million by 2018. The key players in ultrasound ablation segment are InSightec(U.S), Elmed Lithotripsy(Turkey), Ethicon (J&J)(U.S), Misonix Inc.(U.S), USHIFU (U.S.), and Sonora (U.S.), a subsidiary of Misonix. |
Upcoming | |
Asia-Pacific Ultrasound Ablation The Asia-Pacific Ultrasound Ablation Market was pegged at $259 million in 2013 and expected to be $535 million by 2018. The key players in Asia-Pacific Ultrasound Ablation segment are InSightec(U.S), Elmed Lithotripsy(Turkey), Ethicon (J&J)(U.S), Misonix Inc.(U.S), USHIFU (U.S.), and Sonora (U.S.), a subsidiary of Misonix. |
Upcoming | |
European Ultrasound Ablation The European Ultrasound Ablation Market was pegged at $286 million in 2013 and expected to be $500 million by 2018. The key players in European Ultrasound Ablation segment are InSightec(U.S), Elmed Lithotripsy(Turkey), Ethicon (J&J)(U.S), Misonix Inc.(U.S), USHIFU (U.S.), and Sonora (U.S.), a subsidiary of Misonix. |
Upcoming | |
Americas Thermal Ablation The American Thermal Ablation Market was pegged at $3097 million in 2013 and expected to be $5012 million by 2018. The main companies operating in thermal ablation market and extensively covered in this report are Varian Medical systems, Elekta, Biosense Webster, St. Jude Medical Boston Scientfic, Accuray, Medtronic, CR Bard, Others |
Upcoming | |
Europe Coagulation Europe holds the second position in the global coagulation market after the Americas. Germany commanded the largest share (20%) at an estimated $186.9 million in 2013 and is expected to reach $231.1 million by 2018, at a CAGR of 4.5% from 2013 to 2018. The market can be segmented by geographies, end users, companies, and macro indicators. A deep-dive analysis of the top players of this market has been provided in this report. |
Upcoming | |
Asia-Pacific Thermal Ablation The Asia-Pacific Thermal Ablation Market was pegged at $1533 million in 2013 and expected to be $2772 million by 2018. The main companies operating in Asia-Pacific Thermal Ablation market and extensively covered in this report are Varian Medical systems, Elekta, Biosense Webster, St. Jude Medical Boston Scientfic, Accuray, Medtronic, CR Bard, Others. |
Upcoming | |
European Thermal Ablation The European Thermal Ablation Market was pegged at $2132 million in 2013 and expected to be $3328 million by 2018. The main companies operating in European thermal ablation market and extensively covered in this report are Varian Medical systems, Elekta, Biosense Webster, St. Jude Medical Boston Scientfic, Accuray, Medtronic, CR Bard, Others. |
Upcoming | |
European Cardiac Rhythm Management Devices The European Cardiac Rhythm Management Devices Market, mainly driven by Increasing Incidence of Lifestyle Diseases &Cardiovascular Diseases, was pegged at $ 3.16 billion in 2012 and expected to be $ 5.98 billion by 2018.The Cardiac Rhythm Management Devices Market by Geographies, Applications, Technologies, Products, Endusers, Companies and MacroIndicators. Deep dive analysis of the top players of this market have been considered in this report. |
Upcoming | |
Asian Cardiac Rhythm Management Devices The Asian Cardiac Rhythm Management Devices Market is growing at a fast pace.The Cardiac Rhythm Management Devices Market by Geographies, Applications, Technologies, Products, Endusers, Companies and MacroIndicators. Deep dive analysis of the top players of this market have been considered in this report. |
Upcoming |
Healthcare